We offer two innovative collection tubes. First of which we have developed a unique DNA/RNA transport and storage medium that immediately inactivates the viruses ensuring safety of your laboratory personnel.  viRNAtrap™ Collection Tubes preserve the genetic integrity of samples at ambient temperature for weeks. Second of which is RESALIVA™ utilises an absorption sponge to collect saliva samples which is easy-to-use, pain-free, and comfortable.

Our fast and robust nucleic acid extraction is based on magnetic beads technology. viRNAtrap™ CE-IVDR Extraction Kit can be used for manual and automated nucleic acid purification on any open platform. The kit consists of 4 bottles not requiring controlled temperature storage. The isolation process takes 10 minutes only and enables true high-throughput extraction. The kit is CE-IVDR certified. 

GeneSpector offers a groundbreaking method for predicting pregnancy-related complications by analyzing blood samples during the first trimester (10th-13th week). This approach effectively predicts conditions like preeclampsia, and other pregnanc-related complications, significantly improving early intervention and prenatal care. It also identifies undiagnosed chronic hypertension, a key risk factor for complications, offering a high success rate in managing and preventing severe maternal and fetal outcomes.

NGS sequencing solution for various diagnostic applications feasible in any laboratory. Currently developing a kit for diagnosing multiple myeloma, a malignant bone marrow disorder, this innovative approach uses a custom set of oligonucleotides in a well-defined NGS panel followed by bioinformatics analysis to determine the disease cause directly. We also offer custom development of sequencing kits for other genetic-based disorder diagnostics and research.

Now, implemented in a Faculty Hospital in Ostrava in the Czech Republic.

A diagnostic method predicting the severity of infectious disease symptoms days in advance. Using PCR-based detection of specific biomarkers in nasopharyngeal swabs, it identifies high-risk patients early, enabling timely therapy. Applicable to viral, bacterial, and fungal infections, it also monitors treatment efficacy. Optimized for large-scale testing. To develop the methodology and deliver a certified and proven test, GeneSpector decided to found a spin-off company called SeveriDx (www.severidx.com).

A reliable, simple diagnostic solution for hereditary kidney disease ADTKD (Autosomal Dominant Tubulo-Interstitial Kidney Disease). Utilizing a specially developed ELISA-based method to detect the MUC1 protein in blood plasma, this cost-effective technique allows for comprehensive screening and monitoring of disease progression and therapy efficiency. Optimized for large-scale testing, this method provides an accessible alternative to expensive genetic testing and aims to be certified and marketed under a license-based collboration for a global use. 

Imagine a world where clinical diagnostics is done with nothing but a simple card. GeneSpector offers a groundbreaking solution using passive chips with nanofluidic structures for complex sample work-up, analyte detection, and result visualization. This method, executable anywhere—even in field conditions—provides robust, fast results with a simple readout at a low price. To develop the technology, GeneSpector in collaboration with IQS Group decided to found a spin-off company in 2024 called Lab On Card (www.laboncard.com).